Targeting brain protein could halt progression of Alzheimer's

A protein that stimulates the brain to wake up could hold the key to preventative Alzheimer's treatments, an animal study suggests.

Alzheimer's: brain cell showing signs of disease (Photo: Science Photo Library)
Alzheimer's: brain cell showing signs of disease (Photo: Science Photo Library)

A mouse-model study conducted by US researchers suggests that targeting orexin, a neurotransmitter that helps rouse the brain from sleep, could help prevent Alzheimer’s disease in patients who have problems sleeping.

Sleep loss is known to contribute to the growth of brain plaques, early signs of Alzheimer’s disease.

They accumulate in the brain ahead of the onset of the more severe symptoms, such as memory loss. Scientists hope that by slowing or stopping this build-up, they can put a halt on the disease.

In the latest study, published in the Journal of Experimental Medicine, researchers bred genetically-modified mice lacking the gene for producing orexin with those predisposed to developing brain plaques.

Brain plaques halved

The offspring slept for longer and developed only half as many brain plaques as their predisposed parents who had the orexin protein, suggesting that higher levels of the neurotransmitter contribute to producing more brain plaques.

When the scientists reversed the experiment, and looked at mice with artificially increased orexin levels, the mice stayed awake longer and developed more Alzheimer's-like plaques.

Lead author Dr David Holtzman said: ‘This indicates we should be looking hard at orexin as a potential target for preventing Alzheimer’s disease.

‘Blocking orexin to increase sleep in patients with sleep abnormalities, or perhaps even to improve sleep efficiency in healthy people, may be a way to reduce the risk of Alzheimer's. This is important to explore further.’

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Free coronavirus news and resources on GPonline, MIMS and MIMS Learning

Free coronavirus news and resources on GPonline, MIMS and MIMS Learning

As the coronavirus crisis continues, we at Haymarket are constantly seeking new ways...

Quarter of GPs self isolating for coronavirus as Hancock promises 100,000 tests a day

Quarter of GPs self isolating for coronavirus as Hancock promises 100,000 tests a day

Around one in four GPs are self isolating - many of them unnecessarily - as frontline...

Cashflow fears for locums as government relaxes 10-week pension rule

Cashflow fears for locums as government relaxes 10-week pension rule

Locums will have longer to declare pensionable income under plans to relax a 10-week...

More than 6,000 GPs in second wave of doctors given temporary GMC registration

More than 6,000 GPs in second wave of doctors given temporary GMC registration

More than 6,000 GPs who have retired or no longer hold a licence to practise are...

Updated PHE advice on PPE backs eye protection for GPs

Updated PHE advice on PPE backs eye protection for GPs

GPs should wear eye protection in addition to a mask, gloves and apron when providing...

Repurpose industry now to tackle PPE shortage, says doctors' union

Repurpose industry now to tackle PPE shortage, says doctors' union

UK industry should be 'immediately repurposed' to produce personal protective equipment...